(Q27851554)
Statements
1 reference
FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer (English)
1 reference
Caterina Marchio
1 reference
1 March 2010
0 references
70
0 references
5
0 references
2085-94
0 references